<DOC>
	<DOCNO>NCT00101660</DOCNO>
	<brief_summary>The purpose study assess effect investigational drug dasatinib participant chronic phase Philadelphia chromosome chronic myeloid leukemia either resistant intolerant imatinib . Other purpose study identify side effect drug may produce study level dasatanib blood ass efficacy dasatanib treatment leukemia .</brief_summary>
	<brief_title>Study BMS-354825 ( Dasatinib ) Patients With Chronic Myeloid Leukemia Who Are Either Resistant Intolerant Imatinib</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Philadelphia Chromosome</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<mesh_term>Dasatinib</mesh_term>
	<criteria>Age 18 year old . Chronic myeloid leukemia ( CML ) Previous treatment imatinib dose &gt; 600 mg/day AND development progressive disease receive imatinib dose , OR CML resistance imatinib dose less equal 600 mg/day genetic mutation BCRABL gene associate high level resistance imatinib , OR Intolerance imatinib dose Adequate organ function Women able bear child must negative serum urine pregnancy test . Adequate method contraception must use throughout study avoid pregnancy entire interval least 1 month 3 month completion study medication . Woman pregnant breastfeed Men whose sexual partner woman childbearing potential , unwilling unable use acceptable method avoid pregnancy partner entire study period outline Previous diagnosis accelerate phase blast crisis CML . Participants eligible willing undergo transplantation screen period Uncontrolled significant cardiovascular disease Use imatinib within 7 day . Use interferon cytarabine within 14 day Use target smallmolecule anticancer agent within 14 day Use certain medication carry know side effect risk Torsade de Pointes Certain medication irreversibly inhibit platelet function anticoagulant Prior therapy dasatinib .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Chronic phase Philadelphia chromosome chronic myeloid leukemia ( Ph+CML )</keyword>
</DOC>